Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

MedCity Launched at Imperial College London

Published: Tuesday, April 08, 2014
Last Updated: Tuesday, April 08, 2014
Bookmark and Share
MedCity, a major new medical research and translation initiative, was launched at Imperial College London by the Mayor of London.

MedCity brings together the leading centres of medical research in London, Cambridge and Oxford as they work to translate their research into new healthcare applications for the benefit of patients and the economy. 

The new body, which is modelled on the successful Tech City Investment Organisation, will position the London-Oxford-Cambridge life sciences sector as a world-leading cluster that will match financial services in its importance to the UK economy.

MedCity has been established by the Mayor of London and Imperial College Academic Health Science Centre, King's Health Partners and UCL Partners with cooperation from the Universities of Cambridge and Oxford. The organisation's advisory board includes leading life sciences figures such as Imperial's Vice President (Health) Professor Dermot Kelleher, Sir Paul Nurse, Director of the Crick Institute, alongside successful entrepreneurs including Dr Hermann Hauser as well as leading political, medical and charitable representatives.

MedCity is funded by £2.92 million from the Higher Education Funding Council for England and £1.2 million from the Mayor of London's Office.

At the launch event held at Imperial's Hammersmith Campus - adjacent to the College's new research and innovation campus, Imperial West - Imperial College London joined forces with King's, UCL, Cambridge University and Oxford University, as well as charitable and commercial partners, to showcase cutting-edge healthcare applications.

A panel including Professor Jonathan Weber, Vice Dean of Medicine at Imperial, Lara Flynn, Vice President of Circassia, an Imperial College spinout valued at more than half a billion pounds, and the Mayor explored how the 'golden triangle' of scientific innovation can produce even greater benefits for the country's health and economy. 

Professor Dermot Kelleher, Vice President (Health) at Imperial College London, said:

"London is a world leader in medical research. Our unique combination of great universities and first-class research hospitals, dovetailed with access to a critical mass of entrepreneurial talent and a diverse population, puts the capital at the heart of medical discovery and its application. MedCity will allow us to intensify efforts to turn medical innovations into patient benefits and economic value on a national and international scale. 

"This collaboration will lay the foundations for the next generation of medical advances while helping secure the capital's long-term growth. London is powering ahead to a healthier and wealthier future." 

The Mayor of London, Boris Johnson, said: "Together with Oxford and Cambridge we form a 'golden triangle' of scientific innovation and we need to channel that intellectual pre-eminence into a positive impact on our economy. MedCity will span everything from research to clinical trials to manufacturing, across biotech, med tech and health tech. I am in no doubt that having the whole 'chain' from small spin-offs to massive companies doing their research, clinical development and manufacturing here in London and the south east can be as important to our economy as the financial services sector is today."

Professor David Gann, Vice-President (Development & Innovation) at Imperial College London, said: "MedCity will create jobs, attract new investment and accelerate the discovery of new healthcare applications. Imperial is ready to make a substantial contribution to this life sciences innovation ecosystem."

Just before the event, the Mayor visited Imanova: a pioneering imaging company formed by Imperial in collaboration with the Medical Research Council, UCL and King's.

Imanova Chief Executive Dr Kevin Cox and colleagues showed the Mayor how the company is translating cutting-edge medical research from leading universities like Imperial into commercial applications that are vastly improving brain and other scanning technology.

Dr Kevin Cox, CEO of Imanova, said: "Imanova is delighted to have hosted the Mayor's visit today. We are fully behind MedCity as it will position London as the undisputed leader for translational medicine in Europe; increasing inward investment, expanding collaborations and supporting growth. As a leading centre for imaging sciences this will greatly enhance Imanova's ability to attract business from around the world."

At Imanova, Boris Johnson used a novel device based on the Microsoft Kinect camera, which tracked his movements to generate a 3D image of the Mayor's head. This uses Imanova-developed software to track the movements of patients during their PET scan. The technique is particularly useful for patients who may find it difficult to keep still and ensures an accurate, unblurred brain scan is obtained.

Lord Ara Darzi, Professor of Surgery at Imperial and Chair of the London Health Commission said: "MedCity is an exciting initiative for London and the whole country.  My ambition for the Commission is to help London become the healthiest big city in the world and a successful and thriving life sciences sector is crucial to achieving this aim. During its call for evidence it has been clear to the Commission that with increased investment and collaboration the life sciences in London can make a bigger contribution to London's economy. The Commission will be working closely with MedCity as it develops its recommendations that I will present to the mayor in the autumn."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Discovery of Trigger for Bugs’ Defences Could Lead to New Antibiotics
New research shows that sigma54 holds a bacterium’s defences back until it encounters stress.
Friday, August 21, 2015
Breakthrough Could Lead to New Antibiotics
Scientists have exposed a chink in the armour of disease-causing bugs, with a new discovery about a protein that controls bacterial defences.
Friday, August 21, 2015
New Drug Target Identified for Serious Heart and Lung Condition
A gene has been identified that sheds new light on a potentially fatal heart and lung condition and could lead to a new treatment.
Friday, August 14, 2015
Study Finds Brain Chemicals that Keep Wakefulness in Check
Researchers to develop new drugs that promote better sleep, or control hyperactivity in people with mania.
Saturday, August 01, 2015
Fossil Fuel Emissions will Complicate Radiocarbon Dating, Warns Scientist
The paper is published in the journal PNAS.
Tuesday, July 21, 2015
Scientists Find New Variant of Streptococcal Bacteria Causing Severe Infections
Researchers noticed a sharp rise in infections caused by emm89.
Wednesday, July 15, 2015
Gene Therapy for Cystic Fibrosis Shows Encouraging Trial Results
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial.
Friday, July 03, 2015
New Genetic Form of Obesity and Diabetes Discovered
Scientists have discovered a new inherited form of obesity and type 2 diabetes in humans.
Tuesday, June 30, 2015
New Genetic Form of Obesity and Diabetes Discovered
Scientists have discovered a new inherited form of obesity and type 2 diabetes in humans.
Tuesday, June 30, 2015
Researchers Develop New Breath Test to Diagnose Oesophageal and Gastric Cancer
Test will now be tested in a larger trial involving three hospitals in London.
Tuesday, June 23, 2015
'Crumpled' Filter to Slash Energy Consumption
Scientists have developed an ultra-thin, super-strong membrane to filter liquids and gases, with the potential to cut energy consumption in industry.
Friday, June 19, 2015
Imperial Researchers Win Health Foundation Grant for Cancer Innovation Study
Each project will receive over £450,000 of funding to support the research.
Tuesday, May 26, 2015
Engineering Bacteria for Vaccine Delivery
An eight million Euro project has been launched with the aim of engineering bacteria to deliver vaccines against antibiotic-resistant infections.
Monday, May 18, 2015
Diet Swap has Dramatic Effects on Colon Cancer Risk for Americans and Africans
New study confirms that a high fibre diet can substantially reduce risk.
Saturday, May 02, 2015
Alcoholic Hepatitis Treatments Fail to Keep Patients Alive
The study is published in the New England Journal of Medicine.
Friday, May 01, 2015
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!